Anoro Ellipta: Clinical Trials

5 trials of Anoro Ellipta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Recruiting 1
Phase 21Active not recruiting 1
Phase 31Completed 1

Follow Anoro Ellipta: new trials by email Literature Review of Anoro Ellipta trials Research Report on Anoro Ellipta

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Air Pollution and Inhaled Corticosteroids in COPD
LABA+LAMA, LABA+LAMA+ICS, Filtered Air - COPD
Phase 4Not yet recruitingUniversity of British Columbia482025-04-012025-03-27
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
umeclidinium 62.5 µg and vilanterol 25 µg, Revefenacin 175 µg, Formoterol 20 µg, Placebo ( Revefenacin and Formoterol ) - COPD (Chronic Obstructive Pulmonary Disease)
Phase 4RecruitingUniversity of Tennessee Graduate School of Medicine722023-12-052026-10-19
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
Anoro Ellipta, Arnuity Ellipta - Chronic Obstructive Pulmonary Disease
Phase 2Active not recruitingUniversity of Virginia952017-11-052024-11-18
Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs
Relvar ELLIPTA, Symbicort TURBUHALER, Seretide DISKUS - Pulmonary Disease, Chronic Obstructive
CompletedGlaxoSmithKline4502017-06-082020-10-28
Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD
LAMA/LABA, LAMA - COPD
Phase 3CompletedQueen's University172012-01-012017-08-15

Conditions studied

Pulmonary Disease, Chronic Obstructive (5)  ·  Dyspnea (1)  ·  Emphysema (1)  ·  Motor Activity (1)

Sponsors

GlaxoSmithKline (1)  ·  Queen's University (1)  ·  University of British Columbia (1)  ·  University of Tennessee Graduate School of Medicine (1)  ·  University of Virginia (1)

Countries

United States (2)  ·  Canada (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Christopher Carlsten, MD, MPH (1)  ·  Christopher F Rider, PhD (1)  ·  Denis E O'Donnell, MD, FRCPC (1)  ·  Janice Leung, MD, FRCPC (1)  ·  Kun Qing, PhD (1)  ·  Neeloffer Mookherjee, PhD (1)  ·  Neil Alexis, PhD (1)  ·  Shawn Aaron, MD, FRCPC (1)  ·  Yun M Shim, MD (1)

Results publications

PMID 23681559, PMID 25146558